Skip to content
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
Menu
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
news
December 6, 2022
December 7 & 8 Webinars
August 17, 2022
Ethics Approval for EMD-RX5 – Clinical Trials Next
May 25, 2022
EMD-RX5 demonstrates excellent results in Phase 1 study
May 10, 2022
Emyria receives further positive MDMA-analogue screening results
Search
Search
Search
ASX News
General News
Publications
Thought Leadership
Uncategorised